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Deep brain stimulation (DBS) has emerged as a safe, effective, and reversible treatment
for a number of movement disorders. This has prompted investigation of its use for other
applications including psychiatric disorders. In recent years, DBS has been introduced
for the treatment of obsessive compulsive disorder (OCD), which is characterized by
recurrent unwanted thoughts or ideas (obsessions) and repetitive behaviors or mental
acts performed in order to relieve these obsessions (compulsions). Abnormal activity
in cortico-striato-thalamo-cortical (CSTC) circuits including the orbitofrontal cortex (OFC),
anterior cingulate cortex (ACC), ventral striatum, and mediodorsal (MD) thalamus has been
implicated in OCD. To this end a number of DBS targets including the anterior limb of the
internal capsule (ALIC), ventral capsule/ventral striatum (VC/VS), ventral caudate nucleus,
subthalamic nucleus (STN), and nucleus accumbens (NAc) have been investigated for
the treatment of OCD. Despite its efficacy and widespread use in movement disorders,
the mechanism of DBS is not fully understood, especially as it relates to psychiatric
disorders. While initially thought to create a functional lesion akin to ablative procedures, it
is increasingly clear that DBS may induce clinical benefit through activation of axonal fibers
spanning the CSTC circuits, alteration of oscillatory activity within this network, and/or
release of critical neurotransmitters. In this article we review how the use of DBS for OCD
informs our understanding of both the mechanisms of DBS and the circuitry of OCD. We
review the literature on DBS for OCD and discuss potential mechanisms of action at the
neuronal level as well as the broader circuit level.
Keywords: deep brain stimulation, obsessive compulsive disorder, neuromodulation, cortico-striato-
thalamocortical circuit
INTRODUCTION
Approximately 2–3% of Americans suffer from OCD, a mental
illness characterized by chronic intrusive thoughts (obsessions)
and/or repetitive behaviors (compulsions). Half of these patients
experience severe disease that seriously impairs their occupa-
tional, academic, and/or interpersonal functioning (Kessler et al.,
2005). Although behavioral therapy and medical management
benefit some patients, 20–40% of OCD patients—often those
most severely affected—remain refractory to treatment (Skoog
and Skoog, 1999). Lesion procedures such as anterior capsulo-
tomy and dorsal cingulotomy have been available to patients with
refractory OCD for over 40 years (Dougherty et al., 2002; Mian
et al., 2010), however, these procedures have the disadvantage of
being irreversible. In 1999, DBS was introduced as a neurosurgi-
cal treatment for OCD (Nuttin et al., 1999) with the advantage
of being reversible and adjustable. In early clinical trials, two-
thirds of OCD patients treated with DBS showed a statistically
significant improvement in symptoms and global functioning
(Greenberg et al., 2010a).
Despite the clinical benefit of DBS, the mechanisms underly-
ing its therapeutic success remain unclear. First hypothesized to
mimic ablative procedures and produce the functional equivalent
of a lesion (Nuttin et al., 1999), animal and human studies
have indicated a more complex neurophysiological effect. OCD
is thought to arise from abnormal neural activity in the CSTC
circuit, a network involving ACC, OFC, dorsolateral prefrontal
cortex (DLPFC), ventral striatum, MD thalamus, and amygdala
(Rauch et al., 2006; Rotge et al., 2008, 2010; Haber and Brucker,
2009; den Braber et al., 2010). Studies of DBS have elucidated
local cellular mechanisms that influence the function of both the
stimulated target area and distant regions, which may ultimately
modulate pathological network activity in the CSTC circuit. In
this article, we first review the pathophysiology of OCD before
examining the basic mechanisms of action of DBS and apply-
ing what is known about these mechanisms to understand how
DBS functions in OCD. We analyze the results of neuroimaging
studies, intraoperative human recordings, and in vivo and in vitro
animal studies of DBS in order to inform our knowledge of the
mechanisms of DBS and how this increases our understanding of
the pathophysiology of OCD.
PATHOLOGY OF OCD
The CSTC-based theory of behavioral control serves as a use-
ful model for the investigation of mental health disorders such
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FIGURE 1 | Cortico-striato-thalamocortical circuit. Schematic diagram of
the cortico-striato-thalamocortical (CSTC) circuit, which is implicated in the
pathophysiology of OCD. In DBS for OCD, activity within this circuit is
thought to be modulated by high frequency stimulation. DLPFC,
dorsolateral prefrontal cortex; ACC, anterior cingulate cortex; OFC,
orbitofrontal cortex; VMPFC, ventromedial prefrontal cortex. Arrowheads
indicate direction of neural input. Black lines represent connections among
the major structures implicated in DBS for OCD; gray lines indicate
additional connections.
as OCD (Figure 1). OFC is a critical cortical component of the
CSTC implicated in OCD, and extensive evidence links OFC dys-
function to OCD. Positron emission tomography (PET) studies in
patients with OCD have identified increased metabolism in OFC
in the resting state (Baxter et al., 1987, 1988) and increased activ-
ity with symptom provocation has also been observed with PET
and functional magnetic resonance imaging (fMRI). (McGuire
et al., 1994; Rauch et al., 1994; Adler et al., 2000). Additionally,
OFC PET metabolism elevation is correlated with anxiety levels
in OCD patients (Swedo et al., 1989). OFC activation with obses-
sions is not limited to the pathologic state; increased OFC activity
is also seen with PET during stimulation of obsessive thoughts
in healthy controls (Cottraux et al., 1996). A PET study showed
that OFC metabolism decreases with pharmacologic treatment,
and this decrease correlates with several measures of improve-
ment in OCD symptoms (Swedo et al., 1992). The medial OFC
(mOFC) and lateral OFC (lOFC) may be differentially involved
in OCD. The mOFC is active in emotional regulation and positive
valence processing while the lOFC processes negative reinforcers
and fear response (Kringelbach and Rolls, 2004). In OCD, there
may be increased lOFC and decreased mOFC activity (Milad
and Rauch, 2007), although findings are somewhat inconsistent
(Milad and Rauch, 2011). The OFC is also involved in behav-
ioral planning and expected reward valuation. Dysfunctions of
these processes are likely involved in the repetitive compulsions
and driving obsessions of OCD, and may be represented by the
altered OFC activity seen in this disease.
ACC plays a role in motivation and conflict monitoring, as
well as determining discrepancies between desired and antici-
pated state (Graybiel and Rauch, 2000; Del Casale et al., 2011).
These functions are important in OCD, in which obsessions and
compulsions may be in part due to dysfunctional reward signal-
ing and aberrant signaling of conflict between desired and current
state. PET and single photon emission computed tomography
(SPECT) studies have demonstrated increased ACC metabolism
in OCD patients at rest (Swedo et al., 1989; Machlin et al.,
1991; Perani et al., 1995) and PET and fMRI studies have also
found increased ACC activity with symptom provocation (Rauch
et al., 1994; Breiter et al., 1996; Adler et al., 2000) and error or
high conflict trials on an interference processing task (Fitzgerald
et al., 2005; Maltby et al., 2005; Schlosser et al., 2010). ACC
metabolism measured with PET decreases following treatment
with selective serotonin reuptake inhibitors (SSRIs), correlat-
ing with decreases in Yale Brown Obsessive Compulsive Scale
(Y-BOCS) score (Perani et al., 1995), a commonly used metric of
OCD severity. Interestingly, increased PETACCmetabolism prior
to treatment is seen in clomipramine non-responders (Swedo
et al., 1989), perhaps representing a degree of severity or a marker
of different pathological underpinnings resistant to pharmaco-
logic therapy. Lesion of the dorsal anterior cingulate (cingulo-
tomy) can result in long-term improvement in OCD symptoms
in patients refractory to pharmacologic and behavior therapy
(Dougherty et al., 2002). The cingulate cortex has close con-
nections to motor cortex and participates in action selection.
Graybiel and Rauch suggest that OFC and ACC together have
a strong influence on perceived value and corresponding action
selection (Graybiel and Rauch, 2000). The altered activity of both
of these structures seen in OCD may represent abnormal func-
tion and interaction of OFC and ACC in OCD contributing
to dysfunctional valuation and repetitive actions characteristic
of OCD.
The basal ganglia participate in multiple parallel cortico-
basal ganglia circuits and are important in motor inhibition and
release. It has been hypothesized that an analogous role exists
in cognitive circuits in parallel with motor circuitry and may be
involved in the pathophysiology of OCD (Saxena et al., 1998;
Graybiel and Rauch, 2000). In particular, the caudate nucleus has
been implicated in OCD. The caudate plays a role in procedural
learning and may contribute to abnormal processing of behav-
ioral sequences generated by frontal subcortical circuits that have
been hypothesized to exist in OCD (Graybiel and Rauch, 2000;
Saxena and Rauch, 2000). Structural studies have shown altered
caudate volume in OCD (Luxenberg et al., 1988; Scarone et al.,
1992; Robinson et al., 1995), with decreased N-acetyl-aspartate
(NAA), thought to be a marker of neuronal density, in caudate
and putamen (Ebert et al., 1997; Bartha et al., 1998). Functionally,
caudate activity measured with PET is increased at rest (Baxter
et al., 1987, 1988) and increased activity during symptom provo-
cation has been observed with PET and fMRI (Rauch et al., 1994;
Breiter et al., 1996; Simon et al., 2010), correlating with symptom
intensity (McGuire et al., 1994), with decreased activity measured
with PET correlating with improvement in symptoms follow-
ing pharmacologic (Benkelfat et al., 1990) or behavioral therapy
(Baxter et al., 1992). OCD patients have decreased dopamine D2
receptor binding (Denys et al., 2004) and increased dopamine
transporter density (van der Wee et al., 2004) in the caudate,
suggesting dysfunction of this structure and perhaps altered
dopaminergic tone in OCD.
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As part of the involved CSTC circuit, the thalamus has
also been studied in OCD, with some PET study evidence
showing increased activity in the resting state (Swedo et al.,
1989; Perani et al., 1995) and with increased blood flow mea-
sured with H215O PET correlating with symptom intensity
during symptom provocation (McGuire et al., 1994). Prior to
treatment, OCD patients showed correlation of OFC activ-
ity measured with PET with ipsilateral caudate and thalamus
activity, but this correlation disappeared after successful phar-
macologic or behavioral therapy (Baxter et al., 1992; Schwartz
et al., 1996), suggesting that abnormal signaling between these
regions may be involved in OCD pathophysiology (Modell et al.,
1989).
In themedial temporal cortex, the hippocampus and amygdala
bear connections to each other and the prefrontal cortex (PFC),
and these regions may play a role in the pathophysiology of OCD.
The amygdala is critically involved in the association of external
stimuli with emotional value and the acquisition of conditioned
fear responses (Aggleton, 1993; Cahill and McGaugh, 1998). The
hippocampus integrates spatial and affective information (Sesack
and Grace, 2010) and is necessary for context-dependent fear
conditioning (Fanselow, 2000; Maren and Quirk, 2004) and the
behavioral response to stress (Bouton and Bolles, 1979; Bouton
and King, 1983), among other functions. Thus, abnormal activity
in these structures may underlie the anxiety triggered by provoca-
tive simuli which often accompanies a patient’s urge to perform
compulsions.
Multiple imaging studies have highlighted functional and
structural abnormalities in these regions among patients with
OCD as compared to healthy controls. A positive correlation
between symptom intensity and blood flow in the left hip-
pocampus has been demonstrated using PET (McGuire et al.,
1994). fMRI has also revealed increased activation of the medial
temporal cortex when unmedicated patients are exposed to
provocative stimuli that triggers OCD symptoms (Adler et al.,
2000). In structural MRI studies, the mean volume of the hip-
pocampus and amygdala is decreased among OCD patients
(Kwon et al., 2003), and OCD severity appears to be cor-
related with left hippocampal volume (Atmaca et al., 2008;
Atmaca, 2011). MRI has also shown bilateral hippocampal
shape deformity, which may reflect altered neural connections
(Hong et al., 2007). Researchers employing proton magnetic
resonance spectroscopy found decreased NAA/CR (N-acetyl-
aspartate/creatine) and NAA/CHO (N-acetyl-aspartate/choline)
ratios (Atmaca et al., 2009). Reductions in NAA, a primar-
ily intracellular metabolite, are thought to indicate a loss of
neurons. Increases in creatine, an energetic marker, and CHO,
a component of some phospholipids, are thought to reflect
membrane breakdown. Thus, these ratios suggest hippocampal
degeneration.
Despite these results, not all imaging studies have identi-
fied a significant effect in the amygdala and/or hippocampus
(Busatto et al., 2000; Saxena et al., 2004). These discrepan-
cies may arise from variations in the pathophysiology of OCD
depending on severity or subtype of obsessions. In a study using
proton magnetic resonance spectroscopy, patients with autoge-
nous obsessions, which do not emerge in response to identifiable
external stimuli, had elevated NAA/CR ratios in the amygdala and
hippocampus. This increase was not observed in the same brain
regions of healthy controls or patients with reactive obsessions, a
subtype of OCD in which obsessions are evoked by specific exter-
nal stimuli (Besiroglu et al., 2011). In contrast, altered energy
metabolism was found in the ACC, a commonly implicated brain
region in the pathology of OCD, in patients with either sub-
type of OCD. These results suggest that patient categorization
within OCD may reveal effects masked when OCD is studied
as a homogenous disorder. Such consideration of heterogene-
ity may be most important when investigating regions that have
only been weakly implicated in OCD, but may nonetheless signif-
icantly affect pathology and, in turn, treatment, in certain forms
of OCD. Although the hippocampus and amygdala have received
less attention in the literature than ACC or OFC, these regions
may garner greater focus in the future, given recent evidence
that the ameliorating effect of OCD treatments may arise, in
part, from hippocampal neurogenesis (Derrick et al., 2000; Bruel-
Jungerman et al., 2006; Chun et al., 2006; Kitamura et al., 2010;
Stone et al., 2011).
MECHANISMS OF ACTION OF DBS
The longest established application of DBS is for the treatment
of Parkinson’s disease (PD). Accordingly, the majority of stud-
ies of the local and cellular effects of high frequency stimulation
(HFS) pertain to stimulation of STN or globus pallidus internus
(GPi), the two structures targeted for treatment of this disease.
Nonetheless, some mechanisms may be generalizable to DBS for
OCD, thus warranting their review (Table 1).
Table 1 | Mechanisms of action of DBS.
Mechanisms of action of DBS
• Local inhibition
–Conduction block
–Buildup of K+ in submyelin space
–Inactivation of Na+ channels
–Depletion of neurotransmitter (glutamate)
–Release of inhibitory neurotransmitters
–Adenosine
–GABA
–Hyperpolarization of soma
• Local excitation
–Axonal activation
–antidromic
–orthodromic
–Glutamate release from astrocytes
• Modulation of temporal firing pattern
–Desynchronization of neural firing
–Suppression of information transmission through region
• Neurogenesis
–Generation of DGCs
–Integration of DGCs into hippocampal circuits
DGCs: dentate gyrus cells.
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DBS AS FUNCTIONAL LESION-MECHANISMS OF LOCAL
INHIBITION
The clinical outcomes of ablative neurosurgical techniques, such
as anterior capsulotomy and cingulotomy, resemble those of DBS,
which has prompted comparisons of DBS to a lesion (Nuttin et al.,
1999). Inactivation of the STN via injections of lidocaine or the
gamma-aminobutyric acid (GABA) agonist muscimol alleviates
parkinsonian motor symptoms in 1-Methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) treated primates (Wichmann et al.,
1994) and humans with PD (Levy et al., 2001). Muscimol injec-
tion into the ventralis intermedius thalamus of humans has also
been shown to alleviate tremor (Pahapill et al., 1999), suggest-
ing that DBS might achieve its similar therapeutic effect through
local inhibition (Table 1). Single unit extracellular recordings in
animal studies of HFS, the experimental equivalent of DBS, of
the STN, GPi, and thalamus have shown suppression of neuronal
activity in the targeted region (Benazzouz et al., 1995; Boraud
et al., 1996; Benazzouz and Hallett, 2000; Tai et al., 2003; Meissner
et al., 2005). Human studies of DBS of the STN (Filali et al., 2004;
Welter et al., 2004) and GPi (Dostrovsky et al., 2000) using sin-
gle unit recordings have also shown local inhibition. However,
not all studies have corroborated these results; single unit record-
ings conducted during DBS of STN in humans did not show
suppression of the stimulated region (Carlson et al., 2010). Such
discrepancies are quintessential of the study of DBS thus far,
which indicates that DBS may evoke multiple effects, with the
weight of any given mechanism varying.
Evidence for different mechanisms of local inhibition has
emerged, including conduction block, depletion of neurotrans-
mitter, and activation of inhibitory inputs. HFS may cause a
conduction block via a buildup of K+ in the submyelin space
(Bikson et al., 2001; Lian et al., 2003; Bellinger et al., 2008) and
axonal depolarization that inactivates Na+ channels (Beurrier
et al., 2001; Kiss et al., 2002). Depolarization may also result in
glutamatergic release and subsequent depression due to depletion
of the neurotransmitter pool, as has been shown in in vitro studies
of HFS of the thalamus in rodent brain slices (Urbano et al., 2002;
Anderson et al., 2004; Iremonger et al., 2006).
Release of inhibitory neurotransmitters may also suppress
neuronal activity. HFS has been shown to evoke release of adeno-
sine triphosphate (ATP) in the in vitro rodent slice, resulting in
increased extracellular adenosine levels and suppression of tha-
lamic activity via activation of the adenosine A1 receptor (Bekar
et al., 2008). GABAergic afferent inputs may also play a signficant
role in stimulation induced inhibition, especially considering that
stimulation more readily activates axon terminals than local cells
near an electrode (Baldissera et al., 1972; Jankowska et al., 1975;
Gustafsson and Jankowska, 1976). Lee and colleagues (2004)
found that STN stimulation in vitro causes local GABA medi-
ated postsynaptic potentials. Microstimulation of the GPi appears
to cause preferential activation of GABAergic axons (Dostrovsky
et al., 2000), possibly due to the predominance of GABAergic
over glutamatergic terminals in the GPi (Shink and Smith, 1995)
indeed, while stimulating in a region with greater glutamatergic
inputs, the thalamus, Dostrovsky and colleagues (1999) observed
postsynaptically mediated excitation. Results such as these—
excitation in one brain region, inhibition in another—exemplify
the diversity of findings regarding the mechanisms of DBS,
indicating that the neurophysiological effects of DBS are more
nuanced than those of a lesion. The overall effect may depend
in part on characteristics of the region being stimulated and the
convergence of opposing mechanisms.
NEUROPHYSIOLOGICAL RESPONSE OF A NEURON TO HFS
Computational models suggest that DBS has a decoupling effect
within the individual neuron, causing inhibition of the soma and
excitation of the axon (McIntyre et al., 2004; Miocinovic et al.,
2006). The influence of an electric field on a cell is related to
the second derivative of the extracellular potential distribution
along each process of a neuron (McNeal, 1976; Rattay, 1986).
As a result, stimulation both hyperpolarizes and depolarizes a
neuron, depending on the geometric relationship of the elec-
trode to the cell (McIntyre and Grill, 1999; Rattay, 1999). With
the complex three-dimensional branching of the dendritic arbor,
neurons experience hyperpolarization and depolarization, with
the soma tending to hyperpolarize and the axon hillock depolariz-
ing, potentially triggering an action potential. The concentration
of inhibitory inputs on the proximal dendrites and somamay also
enhance this hyperpolarization of the soma, particularly since
axon terminals, including GABAergic inputs, are readily activated
by HFS (McIntyre et al., 2004). Models have also demonstrated
that HFS can cause antidromic activation and “re-orthodromic”
activation, in which the action potential propagates into the ter-
minal. Antidromic activation only occurs when the diameters of
each axonal process fall under a threshold, and propagation sig-
nificantly depends on the geometry of the node of Ranvier at the
axonal bifurcation (Grill et al., 2008).
Experimental results in the rodent and human accord with
these models; electrical stimulation in gray matter activates axons
but not cell bodies (Nowak and Bullier, 1998). With HFS of
the STN, some STN neurons exhibit an increased discharge rate
(Tai et al., 2003), which is hypothesized to arise from activa-
tion of glutamatergic afferents. Electrophysiological recordings
during HFS of the STN have also shown increased output to
recipient nuclei from the targeted region, through either ortho-
dromic or antidromic activation (Windels et al., 2000; Hashimoto
et al., 2003; Maurice et al., 2003). Li and colleagues (2007)
reported antidromic activation of deep layer cortical neurons dur-
ing HFS of the STN. With simultaneous multisite LFP recordings
during HFS of the NAc, researchers observed inhibition of the
OFC, which they linked to antidromic activation of corticostriatal
projections to cortical inhibitory interneurons (McCracken and
Grace, 2007). Inhibition of the output structures of the basal gan-
glia, including the substantia nigra pars reticulara (SNr) and GPi,
has also been demonstrated in rodents and may arise through a
similar mechanism (Burbaud et al., 1994; Benazzouz et al., 1995;
Benazzouz and Hallett, 2000; Anderson et al., 2003). Thus, acti-
vation of axonsmay have distal effects, inducing overall excitation
or inhibition through stimulation of inhibitory interneurons.
MODULATION OF TEMPORAL FIRING PATTERN
Rather than inducing complete local inhibition, DBS may par-
tially dampen neural activity and reshape firing patterns. In
the diseased state, target regions often display abnormal firing
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patterns. In rats with substantia nigra pars compacta (SNC)
lesion induced parkinsonian behaviors, STN neurons exhibit an
irregular bursting pattern as compared to normal rats, despite
equivalent mean firing rates (Tai et al., 2003). Moreover, HFS of
the rodent STN has been shown to alter the bursting pattern of
STN neurons, with no inhibition of the region’s intrinsic activity
(Zheng et al., 2011). This modification of the temporal firing pat-
tern can result in desynchronization of the firing of STN neurons
(Degos et al., 2005). Similar modulation has been demonstrated
in the globus pallidus (GP); during HFS of the GP in MPTP-
treated primates the majority of neurons in the GP exhibited
complex locking to the stimuli, with a stereotypic temporal struc-
ture (Bar-Gad et al., 2004). The temporal firing pattern of the GP
is also modulated by HFS of the STN (Hashimoto et al., 2003).
This reshaping of temporal dynamics may affect information
transmission. Degos et al. (2005) and Zheng et al. (2011) found
that HFS of the STN decreased, but did not completely interrupt,
transmission of information through the STN and regions of the
basal ganglia. Thus, HFS may partially uncouple the targeted site
from upstream and downstream regions while not significantly
altering the intrinsic activity of the site. Debate remains concern-
ing the primary mechanism of this uncoupling; some researchers
have implicated synaptic inhibition (Deniau et al., 2010), while
others have postulated axonal failure (Zheng et al., 2011).
NEUROGENESIS AND PLASTICITY
In contrast to DBS for PD, the therapeutic effect of DBS for
OCD takes weeks to months to manifest, which raises the pos-
sibility of additional mechanisms beyond acute alteration firing
rates and patterns. Similar to recent findings with the use of SSRI
(Malberg et al., 2000; Santarelli et al., 2003), a common treatment
for OCD, DBS may induce hippocampal neurogenesis. Multiple
studies have demonstrated proliferation and/or survival of den-
tate gyrus cells (DGCs) in vivo following tetanic stimulation of
mossy fibers, the entorhinal cortex, or perforant path in rodents
(Derrick et al., 2000; Bruel-Jungerman et al., 2006; Chun et al.,
2006; Kitamura et al., 2010; Stone et al., 2011). Behavioral corre-
lates, involving enhancement of memory and learning, have also
been demonstrated following stimulation, depending on the time
lapse between stimulation and testing. Hamani and colleagues
administered HFS to the anterior thalamic nucleus (ATN) of cor-
ticosterone treated rats, which is known to reduce neurogenesis
and diminish learning and memory performance (Hamani et al.,
2011). Thirty-three days later, the stimulated rodents performed
significantly better on a common memory test, a delayed non-
matching to sample task, as compared to their unstimulated, cor-
ticosterone treated counterparts. This behavioral enhancement
was not evident prior to 33 days, suggestive of long-term plas-
tic changes. Time may also explain a discrepancy in the literature,
in which ATN HFS was shown to impair rodents’ contextual fear
conditioning (Hamani et al., 2010); the researchers did not wait
as long to test the rodents as in their subsequent study (Hamani
et al., 2011). Stone and colleagues (2011) also reported enhance-
ment of mouse spatial memory at 6 weeks, but not 1 week,
following bilateral entorhinal cortex stimulation. Corresponding
to these time points, integration of DGCs into dentate circuits
was observed at 6 weeks but not 1 week following stimulation.
When the DNA alkylating agent temozolomide (TMZ) was used
to obstruct adult neurogenesis, the previous improvements in
spatial memory were not apparent, further substantiating a role
of HFS in adult neurogenesis with behavioral effect. Given the
abnormalities observed in the hippocampus in imaging stud-
ies, hippocampal neurogenesis, and in turn, HFS, may have an
ameliorating effect among such patients.
VARIABILITY OF THE LOCAL EFFECT OF HFS
As shown by the studies described above, a variety of findings have
emerged in the study of mechanisms of DBS. While several stud-
ies have demonstrated partial failure of axonal conduction with
low fidelity to the frequency of stimulation (Urbano et al., 2002;
Zheng et al., 2011), others have reported driving of neurons at
the same frequency as stimulation (Garcia et al., 2003; Hashimoto
et al., 2003; Li et al., 2007). Differences between in vivo and in vitro
preparations, brain regions, species, and normal and diseased tis-
sue may affect the proportion of blocked to transmitted action
potentials and contribute to this discrepancy (Zheng et al., 2011).
Variations between regions in neural and glial cell types as well as
the proportion of local cells versus fibers of passage and afferent
inputsmay also alter the response of the region to stimulation. For
example, some neurons of the STN display a resurgent Na+ cur-
rent which is modified by HFS (Do and Bean, 2003). In contrast,
a similar current has never been demonstrated in the thalamus,
which may explain contrasting results from studies of HFS of this
region (Anderson et al., 2004). Glia, which vary among regions,
may also have a pronounced influence on the effect of HFS: Tawfik
and colleagues (2010) demonstrated that HFS of the thalamus
causes release of glutamate from astrocytes, concurrent with an
abolition of spindle activity in the thalamocortical network. Even
within a given region, multiple neural response types are often
identified (Maurice et al., 2003; Tai et al., 2003; Deniau et al., 2010;
Zheng et al., 2011); such variability may render the results of HFS
of one region less comparable to another.
Although the mechanisms of DBS still remain unclear, this
diversity of findings may indicate that many of these mecha-
nisms occur, with the predominance of their respective effect
dependent on disease state and regional factors. Despite the pos-
sible specificity of findings to target regions, a general hypothesis
may emerge from the debate—DBS suppresses pathological net-
work activity, while allowing normal information transmission to
occur.
EFFECT OF DBS ON OCD CIRCUITRY
While DBS for OCD is a relatively new treatment, several func-
tional imaging and animal studies exist investigating the func-
tional changes underlying the therapeutic effects of DBS. We
examine these in the context of the mechanisms of action of DBS
in order to better understand how DBS effects therapeutic benefit
in OCD.
STN STIMULATION
STN DBS was initially investigated for OCD because of effects on
similar symptoms noted in PD patients. PD patients treated with
STN DBS have decreased obsessive compulsive traits (Alegret
et al., 2001). Case reports of 3 PD patients treated with STN
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DBS who incidentally had comorbid OCD reported substantial
improvement of OCD symptoms with STN stimulation (Mallet
et al., 2002; Fontaine et al., 2004). In all three patients the elec-
trode location was more medial than the standard PD target,
likely contributing to this effect. Subsequently a clinical trial
with patients randomized to actual or sham stimulation in a
crossover design showed that OCD patients with STN DBS tar-
geted to the border of the associative and limbic territories of
the STN, anteromedial to the standard PD target, showed signif-
icant improvement in Y-BOCS scores with stimulation (Mallet
et al., 2008). Stimulation related side effects of STN DBS in
OCD patients include transient dyskinesia, peripheral vertigo,
hypomania, mania, depression, and anxiety (Mallet et al., 2008).
Similar to STN DBS in humans, STN HFS decreases OCD
like behavior in animal models, and this modification may occur
due to the inhibitory and excitatory mechanisms discussed previ-
ously. STN HFS and pharmacologic inactivation in a rat model
both decrease OCD like behavior (Winter et al., 2008b; Klavir
et al., 2009), suggesting that HFS and lesion act similarly in this
paradigm. Anterior STN HFS decreases stereotypic behaviors in
primates with stereotypies induced by injection of the GABA
antagonist bicuculline into the limbic globus pallidus externus
(GPe) (Baup et al., 2008). STN stimulation decreases firing of
SNr and entopeduncular nucleus (EP, a GPi homolog) neurons
while increasing activity of GPe neurons (Benazzouz et al., 1995).
STN receives efferent connections from GPe and projects to GPi
and SNr. GPe projections terminate near STN cells originating
connections to GPi and SNr (Joel and Weiner, 1997) thus stimu-
lation may inhibit STN neural firing and output to SNr and GPi
while being in a position to retrogradely activate GPe axons. In
this way STN stimulation may disrupt the abnormal GPe activity
induced by bicuculline injection in the primate model. Anatomic
studies of this model have shown that the GPe region that induces
stereotypic behaviors when injected with bicuculline receives pro-
jections from dorsal NAc/ventral head of the caudate nucleus and
projects mostly to SNr with some projections to GPi (Francois
et al., 2004). Thus, it is connected to structures known to be
involved in OCD and may modulate activity of circuits involved
in OCD or dopaminergic tone, which may be altered in this con-
dition. The predictions of this model may have implications for
human pathology and STN DBS for OCD. Modulation of GPi
and GPe activity may alter signaling in cortico-basal ganglia cir-
cuits involved in OCD. Overall, these findings provide support to
the theory that DBS, at least in the STN, inhibits local neurons
and their output but causes antidromic activation of efferent pro-
jections and via these mechanisms modulates activity of regions
of pathologic brain activity in OCD.
Research in rats has shown altered neurotransmitter concen-
trations in a number of structures with STN stimulation. Striatal
dopamine increases with STN stimulation in rats (Bruet et al.,
2001; Lee et al., 2006). STN stimulation caused a nonsignificant
trend toward increased dopamine in the NAc core and a signifi-
cant increase of dopamine in the NAc shell as well as decreased
GABA in the ventral tegmental area (VTA) (Winter et al., 2008a).
In this study VTA lesions prevented STN stimulation induced
modulation of NAc dopamine levels suggesting that STN stimula-
tion acts via activation of VTA dopaminergic neurons to increase
dopamine in the NAc. Dopaminergic signaling in the NAc is
involved in motivation and reward; STN DBS induced alteration
of NAc dopamine levels may combat abnormal reward processing
in OCD.
Several functional imaging studies provide insight into altered
metabolism induced by STN DBS (Table 2). In two PD patients,
stimulation of electrode contacts near the border of the associa-
tive and limbic regions of the STN, a location similar to that
used in OCD, induced a hypomanic state; stimulation of these
contacts decreased medial prefrontal cortex (mPFC)/anterior cin-
gulate gyrus and increased left thalamus activation imaged with
PET (Mallet et al., 2007). OCD patients treated with STN DBS
had decreased metabolism in the anterior cingulate gyrus and
medial gyrus of the left frontal lobe during PET imaging, with
decrease in Y-BOCS scores correlating with decreases in OFC and
mPFC metabolism (Le Jeune et al., 2010). STN DBS may mod-
ulate reciprocal direct connections that exist between the STN
and PFC (Degos et al., 2008), thereby causing the observed alter-
ations in prefrontal activity (Le Jeune et al., 2010). An alternative
explanation is that STN stimulation alters activity of subcorti-
cal components of the CSTC circuit, perhaps by altering activity
of the GP, one of the primary basal ganglia output structures,
as discussed above. Ultimately it appears that STN stimulation
decreases ACC activity and that therapeutic effects are addition-
ally related to decreased OFC metabolism. Interestingly, PET
studies have shown decreased metabolism in these two areas with
pharmacologic therapy (Swedo et al., 1992; Perani et al., 1995)
and cingulotomy can be an effective treatment for patients refrac-
tory to pharmacologic and behavioral therapy. These findings
suggest that altered activity of OFC and ACC is a key part of
the dysfunctional circuitry of OCD and that modulation of this
abnormal activity is common to the mechanism of action of
behavioral, pharmacologic, and surgical therapy.
ANTERIOR LIMB OF THE INTERNAL CAPSULE AND
VENTRAL STRIATUM STIMULATION
A number of case reports have documented benefit of stimula-
tion of ALIC or a more ventral target in the ventral ALIC and
ventral striatum which includes the NAc and is termed ventral
capsule/ventral striatum (VC/VS) (Anderson and Ahmed, 2003;
Gabriels et al., 2003; Franzini et al., 2010). This benefit seems
to persist even with blinding to stimulation state (Nuttin et al.,
1999). Larger trials using randomized, blinded assignment to
stimulation versus sham stimulation have strengthened evidence
of benefit of DBS in these regions (Nuttin et al., 2003; Abelson
et al., 2005; Denys et al., 2010; Goodman et al., 2010), with a study
of VC/VS stimulation showing significant sustained improvement
in Y-BOCS scores at three years following surgery (Greenberg
et al., 2006). Unilateral ALIC/NAc DBS has also been studied
and shown to have some effect (Sturm et al., 2003; Huff et al.,
2010). Finally, case reports of stimulation of the ventral caudate
in addition to the NAc have shown significant decrease in Y-BOCS
scores (Aouizerate et al., 2004, 2009). Several side effects have
been reported with ALIC and VC/VS stimulation. Several reports
have described unilateral cheek muscle contraction with acute
ALIC stimulation, corresponding with increased mood (Baker
et al., 2007). Paresthesias and nausea have been associated with
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Table 2 | Findings of functional imaging studies during stimulation of DBS targets used for OCD.
STN DBS ALIC DBS VC/VS DBS
Medial PFC ↓ Mallet et al., 2007 — —
DLPFC — ↑↓ Baker et al., 2007; Van Laere et al.,
2006
—
ACC ↓ Mallet et al., 2007; Le Jeune et al.,
2010
↑↓ Baker et al., 2007; Van Laere et al.,
2006
↑ Baker et al., 2007
Posterior cingulate — ↑ Baker et al., 2007 ↑ Baker et al., 2007
OFC — ↓ Abelson et al., 2005 ↑ Rauch et al., 2006
Medial frontal gyrus ↓ Le Jeune et al., 2010 — —
Superior frontal gyrus — — ↑ Baker et al., 2007
Middle frontal gyrus ↑ Baker et al., 2007 — ↑ Baker et al., 2007
Inferior frontal gyrus ↑ Mallet et al., 2007 — ↑ Baker et al., 2007
Frontal cortex — ↑↓ Nuttin et al., 2003 —
Insula — ↓ Van Laere et al., 2006 —
Inferior parietal gyrus ↑ Mallet et al., 2007 — —
Superior temporal gyrus — ↑ Nuttin et al., 2003 —
Middle temporal gyrus ↑↓ Mallet et al., 2007 ↑ Nuttin et al., 2003 —
Inferior temporal gyrus ↑ Mallet et al., 2007 — —
Middle occipital gyrus ↓ Mallet et al., 2007 — —
Lateral occipital cortex — ↑ Nuttin et al., 2003 —
Bilateral cuneus ↓ Mallet et al., 2007 — —
Striatum — ↑↓ Nuttin et al., 2003; Van Laere et al.,
2006
—
Caudate — ↑ Baker et al., 2007 ↑ Baker et al., 2007
Globus pallidus — ↑ Baker et al., 2007 ↑ Rauch et al., 2006
Putamen — ↑ Baker et al., 2007 ↑ Baker et al., 2007; Rauch
et al., 2006
Amygdala — ↓ Van Laere et al., 2006 —
Thalamus ↑ Mallet et al., 2007 ↑↓ Baker et al., 2007; Van Laere et al.,
2006
↑ Baker et al., 2007; Rauch
et al., 2006
Pons — ↑ Nuttin et al., 2003 —
Correlation with clinical
improvement
Decrease in OFC/ventral medial PFC
correlated with decrease in Y-BOCS
scores (Le Jeune et al., 2010)
Decrease in OFC metabolism seen in
patients with clinical improvement
(Abelson et al., 2005); negative
correlation of decreased left
hippocampus and left posterior
cingulate metabolism with Y-BOCS
scores, positive correlation of reduced
left amygdala and left head of the
caudate neucleus metabolism with
decrease in Y-BOCS (Van Laere et al.,
2006)
—
Arrows indicate direction of change in activity with stimulation of the indicated target.
higher voltage stimulation, perhaps especially with stimulation
of ventral contacts 0 and 1 (Abelson et al., 2005; Baker et al.,
2007). Fatigue lasting for several months and weight changes,
both loss and gain, have been noted (Nuttin et al., 2003). Elevated
mood, hyperactivity, dysinhibition, increased talkativeness, irri-
tability, and decreased need for sleep, sometimes reaching the
level of mania or hypomania may occur with ALIC stimulation,
especially at higher stimulation voltages and with stimulation of
ventral contacts (Gabriels et al., 2003; Nuttin et al., 2003; Abelson
et al., 2005; Chang et al., 2009, 2010). VC/VS stimulationmay also
induce impulsive behavior, hypomania or mania (Denys et al.,
2010; Goodman et al., 2010; Greenberg et al., 2010a; Haq et al.,
2010; Tsai et al., 2010; Luigjes et al., 2011). Similarly to ALIC
stimulation, unilateral smile is common with VC/VS acute stim-
ulation (Greenberg et al., 2006, 2010a; Goodman et al., 2010).
Some patients experience transient stomachaches or nausea with
VC/VS stimulation (Okun et al., 2007; Denys et al., 2010). Other
reported side effects include headaches, cold shivers, difficulty
falling asleep, and paresthesias (Okun et al., 2007; Denys et al.,
2010; Greenberg et al., 2010a; Huff et al., 2010). Some patients
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report cognitive effects such as forgetfulness, word finding dif-
ficulties, verbal perseveration, cognitive clouding, or decreased
concentration (Okun et al., 2007; Denys et al., 2010; Greenberg
et al., 2010a; Huff et al., 2010). VC/VS stimulation can cause acute
emotional changes such as euphoria, sadness, or anxiety occa-
sionally reaching the level of panic attack (Greenberg et al., 2006,
2010a; Goodman et al., 2010; Huff et al., 2010). Panic and anxiety
may be associated with autonomic changes and occur more fre-
quently with stimulation of ventral contacts (Shapira et al., 2006;
Okun et al., 2007; Goodman et al., 2010). Changes in taste, either
decreased taste sensation or transient olfactory and gustatory sen-
sations may occur with VC/VS stimulation, especially with ventral
contact stimulation (Greenberg et al., 2006, 2010a; Okun et al.,
2007; Denys et al., 2010; Goodman et al., 2010). Overall, stim-
ulation induced adverse events are more likely to occur with
stimulation of ventral contacts (Greenberg et al., 2006). Transient
hypomania is the most common side effect experienced immedi-
ately after stimulation is begun and is more common with VC/VS
than STN stimulation (de Koning et al., 2011). In general, stim-
ulation induced adverse effects are almost always transient and
remit with alteration of stimulation settings.
Stimulation of the NAc core and shell may have different
effects. Studies in rats have demonstrated decreased impulsiv-
ity and perseverative behavior with NAc core stimulation but
increased impulsivity and decreased perseverative behavior with
NAc shell stimulation (Sesia et al., 2008, 2010). In contrast,
NAc core lesions increase impulsivity while shell lesions do not
(Pothuizen et al., 2005). NAc lesions have been reported to destroy
the ability to hold reward value over time in a delayed reward
task, resulting in impulsive behavior (Cardinal et al., 2001). This
suggests that the effect of NAc stimulation is more complex than
inhibition. The increase in impulsivity with NAc shell stimulation
may be related to changes in local neurotransmitter concen-
trations: NAc shell HFS also increased concentrations of NAc
dopamine and serotonin (Sesia et al., 2010), while NAc core
stimulation does not in result in any local change in dopamine,
serotonin, or noradrenaline concentrations (van Dijk et al., 2011).
In human subjects NAc stimulation occasionally results in dis-
inhibition, impulsiveness, or mania with increasing stimulation
voltage (Haq et al., 2010; Luigjes et al., 2011) similarly to NAc
lesion these effects may result from local inhibition and dys-
functional reward processing leading to impulsivity. Given the
work by Sesia and colleagues it is possible that impulsivity is
related to the effect of DBS on the NAc shell; alternatively stim-
ulation could be causing an inhibitory effect analogous to a core
lesion. The NAc core and shell have different inputs and projec-
tions, likely contributing to the observed differences between core
and shell stimulation. The shell has reciprocal projections with
VTA that may contribute to changes in dopamine concentrations
with stimulation. STN stimulation also results in increased NAc
dopamine concentrations, suggesting that NAc dopamine may be
important for the observed therapeutic effects of DBS in OCD.
However, increased NAc dopamine may also contribute to dys-
functional reward signaling and increased impulsivity which can
be seen as a side effect of both STN and NAc stimulation.
HFS and low frequency stimulation (LFS) of the NAc have
different effects on neural firing rates and patterns. NAc core
HFS but not LFS increases slow local field potential (LFP) oscil-
lations in OFC and decreases firing of OFC neurons, likely via
antidromic activation of corticostriatal projections, activating
inhibitory interneurons (McCracken and Grace, 2007). Low fre-
quencyNAc stimulation resulted in increased theta activity inMD
thalamus and NAc, while HFS increased beta power in OFC and
MD thalamus and gamma power in OFC, mPFC, and MD thala-
mus. HFS additionally increased beta coherence betweenMD tha-
lamus and OFC, mPFC, and NAC and gamma coherence between
OFC-PFC and OFC-MD thalamus while LFS decreased OFC-
PFC and OFC-MD thalamus gamma coherence (McCracken and
Grace, 2009). Because fast oscillations are generated by synchro-
nization in inhibitory interneuron networks (Traub et al., 2004),
the authors postulate that NAc HFS may generate therapeutic
effects via synchronization of inhibition in dysfunctional OCD
circuits. As discussed above, in untreated OCD patients correla-
tion between OFC and ipsilateral thalamus and caudate activity
measured with PET has been reported with disappearance of
this correlation following treatment (Baxter et al., 1992; Schwartz
et al., 1996); perhaps NAc DBS synchronizes inhibition of these
pathologically hyperactive circuits. Interestingly, OCD patients
have increased EEG theta power especially in frontal temporal
and frontal occipital regions (Desarkar et al., 2007) and decreased
beta power (Kuskowski et al., 1993), which one study reported
localized to frontal regions (Serra et al., 1994). Thus, the thera-
peutic effects of NAc DBS may be related to the reversal of these
abnormal oscillations.
Behavioral studies also support the different effects of NAc
HFS and LFS. Stimulation of the NAc core or shell decreases
compulsive behavior in rats (Mundt et al., 2009), however this
effect is seen only with HFS and not with LFS (van Kuyck et al.,
2008). In fact, increased compulsive behavior was observed in a
rat repetitive and compulsive behavior model with NAc LFS or
lesion (van Kuyck et al., 2003). The opposite effects of HFS and
LFS on synchronization may be related to the increased compul-
sive behavior with LFS seen in this study. The similar behavioral
effects of LFS and lesion in this study suggest that LFS of the NAc
may have some inhibitory characteristics. The lesion like effects
of both HFS and LFS in different behavioral experiments despite
clear behavioral and neurophysiological effects of HFS and LFS
when studied together demonstrate that the mechanism of DBS
is more complicated than simple inhibition. Frequency modu-
lation of antidromic and orthodromic axonal conduction and
different effects on cell bodies and axons likely contribute to these
complexities.
DBS in the region of the ALIC and the ventral striatum in
OCD patients alters activity in structures known to be involved
in OCD, particularly OFC and ACC (Table 2). In one PET study
ALIC DBS decreased OFC metabolism in two patients who ben-
efited from stimulation but did not alter OFC metabolism in a
third patient who experienced no benefit from DBS (Abelson
et al., 2005), suggesting that modulation of OFC activity is impor-
tant to the therapeutic effect of ALIC DBS. Frontal metabolism
was decreased and striatal activity increased with ALIC DBS in
two patients who underwent PET in one study (Nuttin et al.,
2003). While studies of OCD patients generally indicate increased
activity in areas such as OFC, caudate and ACC with decreased
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activity following successful treatment, discrepancies in findings
suggest that OCD pathophysiology and therapeutic mechanisms
are likely more complicated than simple increases and decreases
in activity. Contrary to the findings of Nuttin and colleagues, Van
Laere et al. used PET to find preoperative decreased metabolism
in ventral PFC and dorsal anterior cingulate and increased
metabolism in ventral striatum in a group of six OCD patients
(Van Laere et al., 2006). Following several months of ALIC stim-
ulation these patients demonstrated decreased metabolism in
subgenual ACC and right DLPFC, with normalization of ventral
striatum metabolism. Additionally, decrease in ventral striatum
metabolism correlated with decrease in Y-BOCS scores while
increased preoperative subgenual ACC activity was predictive of
positive response to stimulation. Thus, ALIC DBS likely acts by
modulating abnormal activity in circuits involving OFC, ACC,
and striatum.
ALIC and VC/VS stimulation induce changes in activity in
similar brain regions. In a case report of one patient with a
VC/VS electrode studied with fMRI, stimulation of a contact
located in the ALIC resulted in activation in the middle frontal
gyrus, MD thalamus, ACC, head of the caudate nucleus, and
GP. Stimulation of the ventral most contact in the same patient,
located in the ventral striatum, also resulted in activation of MD
thalamus and head of the caudate nucleus as well as posterior
cingulate cortex and superior, middle, and inferior frontal gyrus
(Baker et al., 2007). In a group of six patients with therapeu-
tic benefit from VC/VS stimulation PET showed increased blood
flow in mOFC, subgenual ACC, putamen, GP, and thalamus with
stimulation (Rauch et al., 2006), although this study took place
soon after electrode implantation and before subjects had been
exposed to chronic stimulation which may alter the findings,
especially considering the often delayed therapeutic effects of DBS
for OCD. Overall, both VC/VS and ALIC stimulation seem to
cause changes in activity in regions involved in OCD, includ-
ing OFC, ACC, striatum, and thalamus. While the direction of
change is not always consistent, this may reflect a modulation
rather than inhibition of abnormal activity in these areas. One
possible mechanism for changes observed with VC/VS stimula-
tion is antidromic activation of corticostriatal fibers modulating
CSTC circuits. OFC and ACC have bidirectional connections
with thalamus passing in the region of VC/VS, thus stimulation
may orthodromically and antidromically stimulate these tracts to
modulate OFC, ACC, and thalamic activity (Rauch et al., 2006).
ALIC stimulation may affect projections from OFC/subgenual
ACC to thalamus running in the internal capsule or frontostriatal
projections. Capsulotomy is thought to act by disrupting recipro-
cal projections between the OFC and MD thalamic nucleus that
travel through the internal capsule; ALIC stimulation may act in
a similar way. It has been hypothesized that the dysfunctional cir-
cuitry of OCD involves pathological positive feedback in these
OFC-thalamic connections (Modell et al., 1989). DBS may act
to dampen this hyperactivity and disrupt pathological signaling.
Finally, as well as modulating activity in the structures and cir-
cuits targeted, DBS may affect neighboring structures and tracts.
Relative location of DBS leads to particular fiber tracts may result
in differential modulation of separate cortical subcortical circuits
(Greenberg et al., 2010b). This may have an important impact on
differing clinical effects of DBS for OCD and may explain some
of the discrepancies in functional imaging findings.
CONCLUSION
Accumulating evidence suggests that DBS is an effective therapy
for treatment resistant OCD. Despite its efficacy, its mechanism
remains poorly understood. As this treatment gains increasing
acceptance and use more extensive studies in human and ani-
mal subjects may help to elucidate how DBS alters and remedies
OCD pathology. DBS appears to alter activity in a number of
regions with abnormal activity in OCD including OFC, ACC,
and striatum, providing further evidence for the involvement of
these regions in OCD pathology. Multiple effects of DBS on neu-
ral activity have been reported. DBS inhibits local neural firing
while activating antidromic and orthodromic axonal conduction.
It alters concentrations of excitatory and inhibitory neurotrans-
mitters. It alters neural firing patterns, information transmission,
and coherence between different regions. It may even affect neu-
rogenesis. Ultimately, the mechanism of action behind the ther-
apeutic effects of DBS in OCD is likely comprised of a complex
combination of these effects.
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